# Observational Leukemia, Myeloid, Acute studies: 91 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 91 trials that are observational for Leukemia, Myeloid, Acute that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Leukemia, Myeloid, Acute studies: 91 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/leukemia-myeloid-acute

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 91
- Recruiting or not yet: 91
- Read on: November 19, 2026

## Trials

The 25 newest of 91, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 5, 2026 | NCT07919119 | Risk Stratification Value of Deep NGS-MRD Detection in Acute Myeloid Leukemia Patients After Allo-HSCT | Institute of Hematology & Blood Diseases Hospital, China | Observational | Not yet recruiting | Measurable Residual Disease, Acute Myeloid Leukemia | 169 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919119) |
| October 26, 2026 | NCT07895901 | Characterization of CD180 Protein Expression in Myeloid Hematological Malignancies by Flow Cytometry | University Hospital, Strasbourg, France | Observational | Recruiting | Acute Myeloid Leukemia, Myeloid Hematological Malignancies, Normal Hematopoietic Stem and Progenitor Cells | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895901) |
| September 9, 2026 | NCT07810829 | Prognostic Value of CAR, AFR and Ferritin in Non-M3 AML | Assiut University | Observational | Not yet recruiting | Acute Myeloid Leukemia, Non-M3 Acute Myeloid Leukemia, De Novo Acute Myeloid Leukemia With Multilineage Dysplasia | 208 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07810829) |
| September 3, 2026 | NCT07802015 | Home-based Intravenous Cytarabine Treatment for Acute Myeloid Leukemia: a National Danish Study of Feasibility, Costs, and Implementation | Zealand University Hospital | Observational | Not yet recruiting | Hematologic Cancer, Acute Myeloid Leukaemia (AML), Hospital At Home, Home-based Chemotherapy | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07802015) |
| August 13, 2026 | NCT07763054 | Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | Observational | Recruiting | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Lymphoma, Multiple Myeloma, Chronic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763054) |
| August 7, 2026 | NCT07751588 | Plasma ctDNA Monitoring in Pediatric Acute Leukemia | Institute of Hematology & Blood Diseases Hospital, China | Observational | Not yet recruiting | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07751588) |
| August 3, 2026 | NCT07743047 | Harnessing the Immunosuppressive Leukemic Microenvironment to Engineer T Cells With Enhanced Anti-tumor Functionality | IRCCS San Raffaele | Observational | Not yet recruiting | Acute Myeloid Leukemia | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07743047) |
| July 21, 2026 | NCT07717164 | PRAISE-IR Versus CIBMTR Controls | Miltenyi Biomedicine GmbH | Observational | Not yet recruiting | ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myeloid Leukemia), MDS (Myelodysplastic Syndrome) | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07717164) |
| July 2, 2026 | NCT07680868 | Caris Chromoseq Data Collection | Caris Science, Inc. | Observational | Recruiting | Acute Myeloid Leukemia (AML), Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases, Myelodysplatic Syndromes... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680868) |
| June 26, 2026 | NCT07670130 | Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis | The First Affiliated Hospital of Soochow University | Observational | Recruiting | Acute Myeloid Leukemia (AML) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07670130) |
| June 4, 2026 | NCT07627568 | Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition. | University of Freiburg | Observational | Recruiting | Acute Myeloid Leukemia | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07627568) |
| May 29, 2026 | NCT07613385 | Individualized AML Treatment | City of Hope Medical Center | Observational | Recruiting | Relapsed/Refractory Acute Myeloid Leukemia (AML) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07613385) |
| May 7, 2026 | NCT07572695 | Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Observational | Not yet recruiting | Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia, AML, Relapsed/Refractory | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07572695) |
| May 6, 2026 | NCT07570407 | Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation | University Hospital Pilsen | Observational | Recruiting | Allogeneic HSCT, Posttransplant Complications, GvHD, Relapse, Acute Myeloid Leukemia | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07570407) |
| May 6, 2026 | NCT07570056 | Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance) | University of Utah | Observational | Not yet recruiting | Myelodysplastic Syndromes, Acute Myeloid Leukemia | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07570056) |
| April 17, 2026 | NCT07537738 | Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia | Peking University People's Hospital | Observational | Recruiting | Acute Myeloid Leukemia (AML), MLL Rearrangement | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07537738) |
| April 6, 2026 | NCT07511829 | WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve... | University of Oxford | Observational | Recruiting | MDS (Myelodysplastic Syndrome), AML (Acute Myeloid Leukemia) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07511829) |
| March 30, 2026 | NCT07500441 | Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML | Peking University People's Hospital | Observational | Recruiting | Acute Myeloid Leukemia (AML) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07500441) |
| March 19, 2026 | NCT07483749 | HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors | The Children's Hospital of Zhejiang University School of Medicine | Observational | Not yet recruiting | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoma, Leukemia, Pediatric | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07483749) |
| March 5, 2026 | NCT07450872 | Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors | The Children's Hospital of Zhejiang University School of Medicine | Observational | Recruiting | Cancer, Glioma, Leukemia (Both ALL and AML) | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07450872) |
| February 19, 2026 | NCT07420790 | Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for... | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Observational | Recruiting | Acute Myeloid Leukemia | 1,941 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07420790) |
| January 15, 2026 | NCT07343687 | Clinico-hematological and Coagulation Profiles in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Intensive Induction... | Assiut University | Observational | Not yet recruiting | Acute Myeloid Leukemia | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07343687) |
| December 8, 2025 | NCT07269067 | Automated vs Manual Flow-cytometry Gating for Measurable Residual Disease in Acute Myeloid Leukaemia (DUALFLOW) | University Hospital, Bordeaux | Observational | Not yet recruiting | Leukemia, Myeloid, Acute | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07269067) |
| November 28, 2025 | NCT07254312 | Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid... | Fondazione IRCCS Policlinico San Matteo di Pavia | Observational | Recruiting | AML (Acute Myelogenous Leukemia | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07254312) |
| November 25, 2025 | NCT07249476 | Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia | Nantes University Hospital | Observational | Not yet recruiting | Leukaemia (Acute Myeloid), Leukaemia (Acute Lymphoblastic), Myelodysplastic Syndrome | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07249476) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assiut University | 5 |
| Assistance Publique - Hôpitaux de Paris | 5 |
| Peking University People's Hospital | 3 |
| National Cancer Institute (NCI) | 3 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 2 |
| Wake Forest University Health Sciences | 2 |
| The Children's Hospital of Zhejiang University School of Medicine | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Ruijin Hospital | 2 |
| Nantes University Hospital | 2 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2 |
| Acute Leukemia French Association | 1 |
| Hospices Civils de Lyon | 1 |
| Caris Science, Inc. | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| Great Ormond Street Hospital for Children NHS Foundation Trust | 1 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 1 |
| University of Rochester | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| [Miltenyi Biomedicine GmbH](https://specstream.ai/data/clinical-trials/company/miltenyi-biomedicine-gmbh) | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
| University Hospital Pilsen | 1 |
| University Hospital, Bordeaux | 1 |
| Technische Universität Dresden | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 26 |
| China | 15 |
| France | 14 |
| Italy | 10 |
| Germany | 4 |
| United Kingdom | 2 |
| Czechia | 2 |
| South Korea | 2 |
| Lithuania | 2 |
| Australia | 1 |
| Austria | 1 |
| Turkey (Türkiye) | 1 |
| Canada | 1 |
| Colombia | 1 |
| Malawi | 1 |
| Greece | 1 |
| Israel | 1 |
| Egypt | 1 |
| Jordan | 1 |
| Poland | 1 |
| Romania | 1 |
| Spain | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Argentine restaurants in the United States](https://specstream.ai/data/businesses/argentine-restaurants/united-states)
- [Logging contractors in the United States](https://specstream.ai/data/businesses/logging-contractors/united-states)
- [B2B water treatment companies in the United States](https://specstream.ai/data/businesses/b2b-water-treatment-companies/united-states)
- [Nephrology practices in the United States](https://specstream.ai/data/businesses/nephrology-practices/united-states)
- [Business management services in the United States](https://specstream.ai/data/businesses/business-management-services/united-states)
- [Pediatric pulmonology practices in the United States](https://specstream.ai/data/businesses/pediatric-pulmonology-practices/united-states)
